Finland
# |
Name |
EBIT |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 305.41 M
|
Dec. 31, 2023 | USD 45.55 | -0.27% |
|
Finland |
|
2 |
USD 28.86 M
|
Dec. 31, 2023 | USD 26.42 | 0.60% |
|
Finland |
|
3 |
USD 1.73 M
|
Dec. 31, 2023 | USD 3.51 | -13.37% |
|
Finland |
|
4 |
USD 918.11 K
|
Dec. 31, 2023 | USD 1.68 | 1.85% |
|
Finland |
|
5 |
USD -1.30 M
|
Dec. 31, 2023 | USD 8.76 | -1.71% |
|
Finland |
|
6 |
USD -4.76 M
|
Dec. 31, 2023 | USD 4.48 | 0.37% |
|
Finland |
|
7 |
USD -11.92 M
|
Dec. 31, 2023 | USD 3.59 | 3.74% |
|
Finland |
|
8 |
USD -22.66 M
|
Dec. 31, 2023 | USD 1.33 | 4.66% |
|
Finland |
|
9 |
USD -31.53 M
|
Dec. 31, 2023 | USD 2.50 | 2.59% |
|
Finland |
The Pharmaceuticals company in Finland with the highest EBIT is Orion Oyj (Helsinki Stock Exchange: ORNBV.HE) at USD 305.41 M.
The Pharmaceuticals company in Finland with the lowest EBIT is Faron Pharmaceuticals Oy (LSE: FARN.L) at USD -31.53 M.
The top 10 Pharmaceuticals companies in Finland by EBIT are Orion Oyj, Revenio Group Oyj, Biohit Oyj, Herantis Pharma Oyj, Nexstim Plc, Optomed Oyj, Nordhealth AS, Nanoform Finland Oyj and Faron Pharmaceuticals Oy.
The bottom 10 Pharmaceuticals companies in Finland by EBIT are Faron Pharmaceuticals Oy, Nanoform Finland Oyj, Nordhealth AS, Optomed Oyj, Nexstim Plc, Herantis Pharma Oyj, Biohit Oyj, Revenio Group Oyj and Orion Oyj.